Lupin Ltd share price logo

Lupin Ltd

NSE: LUPIN

BSE: 500257

Mid Cap

Healthcare Sector

Pharma Sector

₹1919.20

-44.80

(-2.28%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Lupin shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-22%

Searches for Lupin on INDmoney have decreased by 22% over the last 30 days.

Investment activity on INDmoney

+12.62%

Investment activity in Lupin among INDmoney users has increased by 12.62% over the last 30 days.

Among the most traded stocks

172nd

Lupin was the 172nd most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

31 days

INDmoney investors hold Lupin shares for an average of 31 days.

Key Events for Lupin

Upcoming Events

Next Results Date
03/11/2026

Last Dividend Declared

₹18.00 per share, declared on 07/05/2026

View Dividend History

Lupin Stock Performance

as on October 22, 2026 at 8:15 pm IST

  • Day's Low

    Day's High

    ₹1,896.10
    ₹1,945.70
    downward going graph

    1.20%

    Downside

    1.38%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,896.10
    ₹2,529.50
    downward going graph

    1.20%

    Downside

    31.80%

    Upside

    downward going graph

Lupin share price movements today

Previous Close
₹1,964.00
Open
₹1,921.60
Volume
5.70L
Upper Circuit
₹2,160.40
Lower Circuit
₹1,767.60
Day's Low - High
₹1,896.10 - ₹1,945.70
52 Week Low - High
₹1,896.10 - ₹2,529.50

Lupin Historical Returns

1 Month Return
-8.01 %
3 Month Return
-18.4 %
1 Year Return
+ 1.25 %
3 Year Return
+ 68.15 %
5 Year Return
+ 113.64 %

Lupin Fundamentals

as on October 22, 2026 at 2:45 pm IST

Market Cap

₹89,811.75 Cr

Return on Equity (ROE)

23.4

PE Ratio (TTM)

15.85

Return on capital employed (ROCE)

27.47

Industry PE ratio

49.74

Beta (LTM)

0.5

P/B Ratio

3.51

Dividend Yield

0.78

PEG Ratio

0.37

Quarterly Earnings Growth YOY

16.01

EPS (TTM)

117.14

Book Value

490.99

Lupin Stock Valuation

as on October 22, 2026 at 2:45 pm IST

Lupin in the last 5 years

  • Overview

  • Trends

Lowest (-6437.86x)

December 3, 2018

Today (15.85x)

October 21, 2026

Industry (49.74x)

October 21, 2026

Highest (517.33x)

December 2, 2022

LowHigh

Today’s Price to Earnings Ratio: 15.85x

Lupin Technical Analysis

Track how Lupin technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish10
Bullish1
Neutral4

Oscillators

Name

Value

Action

MACD level (12,26)
-1.04
Bearish
CCI (20)
46.52
Neutral
RSI (14)
41.13
Neutral
Momentum (10)
-2.3
Bullish
ADI (14)
19.99
Neutral
Ultimate Oscillator (7,14,28)
36.94
Neutral

Moving Averages

Name

Value

Action

SMA (20)
1916.62
Bearish
EMA (20)
1915.68
Bearish
VWMA (20)
1915.47
Bearish
SMA (50)
1916.32
Bearish
EMA (50)
1916.85
Bearish
SMA (200)
1923.42
Bearish
EMA (200)
1922.16
Bearish
KAMA (200)
1917.37
Bearish
DEMA (200)
1916.75
Bearish

Lupin Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lupin with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Lupin Ltd image
Lupin Ltd
HOLD89,811.7522.73%0.635,35527,958
Sanofi India Ltd image
Sanofi India Ltd
BUY6,511.27-13.25%0.003261,837
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY90,840.6625.43%0.603,50233,653
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
BUY1,11,451.1024.48%0.695,02651,180
Abbott India Ltd image
Abbott India Ltd
BUY54,570.005.38%0.001,4146,445
See all

Market expectation of Lupin Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

HOLD

40.00%

Buy

31.43%

Hold

28.57%

Sell

Lupin Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
5,079.88
4,895.11
5,514.34
5,497.01
5,618.56
5,562.2
6,163.75
6,831.43
7,100.45
7,391.91
8,217.23
Other Income
29.37
29.25
67.78
42.29
53.71
56.95
79.04
90
114.7
140.71
130.32
Total Income
5,226.78
4,990.04
5,668.11
5,715.02
5,821.42
5,724.08
6,347.38
7,137.51
7,282.22
7,615.37
8,407.21
Expenses
4,159.47
3,963.94
4,359.36
4,332.37
4,411.81
4,345.96
4,541.1
4,706.18
5,332.24
5,120.42
5,827.36
Operating Profit
920.41
931.17
1,154.98
1,164.64
1,206.75
1,216.24
1,622.65
2,125.25
1,768.21
2,271.49
2,389.87
Operating Profit Margin %
18.12%
19.02%
20.95%
21.19%
21.48%
21.87%
26.33%
31.11%
24.9%
30.73%
29.08%
Profit Before Interest, Tax and Depreciation
1,067.31
1,026.1
1,308.75
1,382.65
1,409.61
1,378.12
1,806.28
2,431.33
1,949.98
2,494.95
2,579.85
Interest
74.01
71.29
68.01
70.87
66.89
89.1
91.76
107.59
114.98
120.16
109.64
Depreciation
257.2
457.1
247.71
256.92
271.45
393.18
298.98
316.77
312.96
446.79
452.85
Profit Before Tax
736.1
497.71
993.03
1,054.86
1,071.27
895.84
1,415.54
2,006.97
1,522.04
1,928
2,017.36
Tax Paid
117.4
129.49
187.49
195.38
212.41
113.46
194.08
522.14
341.53
459.33
600.38
Profit After Tax
618.7
368.22
805.54
859.48
858.86
782.38
1,221.46
1,484.83
1,180.51
1,468.67
1,416.98
Total Net profit including share of profit / Loss from associate company
618.7
368.22
805.54
859.48
858.86
782.38
1,221.46
1,484.83
1,180.51
1,468.67
1,416.98
EPS
13.47
7.89
17.58
18.7
18.75
16.93
26.7
32.36
25.74
34.83
30.95
Actual EPS
13.47
7.89
17.58
18.7
18.75
16.93
26.7
32.36
25.74
34.83
30.95
Adjusted EPS
13.47
7.89
17.58
18.7
18.75
16.93
26.7
32.36
25.74
34.83
30.95
Diluted EPS
13.41
7.86
17.52
18.64
18.69
16.87
26.62
32.28
25.67
34.75
30.89

Lupin Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
15,559.84
14,318.05
15,142.8
14,926.99
16,192.79
16,269.98
19,656.34
22,192.11
27,487.54
Other Income
153.87
431.22
617.8
137.62
142.05
73.36
120.17
195.82
424.45
Total Income
15,958.02
15,095.78
15,992.56
15,300.58
16,547.53
16,715.02
20,130.99
22,903.72
28,382.48
Expenses
14,120.99
12,443.82
13,772.03
12,596.08
16,118.26
14,843.54
16,200.3
17,424.59
19,699.94
Operating Profit
1,438.85
1,874.23
1,370.77
2,330.91
74.53
1,426.44
3,456.04
4,767.52
7,787.6
Operating Profit Margin %
9.25%
13.09%
9.05%
15.62%
0.46%
8.77%
17.58%
21.48%
28.33%
Profit Before Interest, Tax and Depreciation
1,837.03
2,651.96
2,220.53
2,704.5
429.27
1,871.48
3,930.69
5,479.13
8,682.54
Interest
204.35
302.49
362.98
140.64
142.77
274.3
311.61
294.87
434.49
Depreciation
1,085.87
846.05
970.22
887.41
1,658.71
880.69
1,196.81
1,169.26
1,375.5
Profit Before Tax
546.81
1,503.42
887.33
1,676.45
-1,372.21
716.49
2,422.27
4,015
6,872.55
Tax Paid
288.46
887.94
1,157.11
448.52
137.15
268.8
486.7
708.74
1,517.08
Profit After Tax
258.35
615.48
-269.78
1,227.93
-1,509.36
447.69
1,935.57
3,306.26
5,355.47
Total Net profit including share of profit / Loss from associate company
258.35
615.48
-269.78
1,227.93
-1,509.36
447.69
1,935.57
3,306.26
5,355.47
EPS
5.56
13.61
-5.96
26.84
-33.65
9.46
42.05
71.95
128.45
Actual EPS
5.56
13.61
-5.96
26.84
-33.65
9.46
42.05
71.95
128.45
Adjusted EPS
5.56
13.61
-5.96
26.84
-33.65
9.46
42.05
71.95
128.45
Diluted EPS
5.54
13.55
-5.97
26.72
-33.65
9.41
41.87
71.69
128.11

Lupin Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
-382.39
4,113.51
1,751.19
1,665.97
1,468.84
1,821.76
367.31
1,897.24
3,648.36
2,999.94
7,334.5
Cash Flow from Investing Activities
-947.13
109.35
2,023.29
-2,297.12
1,780.12
-561.96
2,197.31
-1,286.77
-1,712.2
-4,171.89
-3,864.59
Cash Flow from Financing Activities
5,836.38
433.18
-1,492.09
744.13
-890.58
-1,885.27
-1,572.32
-337.25
-2,184.21
1,731.88
-845.87
Net Cash Flow
-1,314.84
2,019.25
728.97
-872.37
1,685.25
-1,303.09
87.22
273.22
-248.05
559.93
2,624.04

Lupin Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters
47.04%
47.01%
46.98%
46.96%
46.95%
46.92%
46.9%
46.9%
46.89%
46.86%
46.85%
46.84%
DII
29.73%
27.76%
26.78%
25.09%
24.74%
25.41%
25.56%
26.55%
25.58%
25.32%
24.65%
23.78%
FII
16.11%
18.28%
19.32%
21.5%
22.04%
21.46%
21.25%
20.49%
21.49%
21.71%
22.42%
23.28%
Government
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0%
0%
0%
Public
7.11%
6.93%
6.92%
6.44%
6.26%
6.2%
6.28%
6.06%
6.03%
6.11%
6.08%
6.09%
Total Outstanding Shares
45,53,26,550
45,56,78,908
45,59,15,953
45,61,43,312
45,62,34,542
45,65,65,045
45,67,16,123
45,67,57,868
45,67,98,806
45,71,79,111
45,72,32,536
45,72,89,972
Total Shareholders
2,81,542
2,80,248
2,88,537
2,79,280
2,81,988
2,83,210
2,86,604
2,80,256
2,88,931
2,90,411
3,00,283
2,97,301

Mutual Funds Buying / Exiting Lupin

Holdings as of 15 Oct 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Lupin

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Mirae Asset Midcap Fund Direct Growth

Mirae Asset Midcap Fund Direct Growth

₹617.61 Cr

₹109.55 Cr (+21.56%)

3.34%

Mirae Asset Large & Midcap Fund Direct Plan Growth

Mirae Asset Large & Midcap Fund Direct Plan Growth

₹755.99 Cr

₹60.38 Cr (+8.68%)

1.87%

Mutual Funds Exiting Lupin

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Lupin Corporate Actions

View detailed summary of the earnings and dividend history of Lupin.

  • Lupin Ltd Earnings Results

    Lupin Ltd’s net profit jumped 16.08% since last year same period to ₹1,415.00Cr in the Q1 2026-2027. On a quarterly growth basis, Lupin Ltd has generated -3.1% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Lupin Ltd Dividends May,2026

    In the quarter ending March 2026, Lupin Ltd has declared dividend of ₹18.00 per share on 07 May 2026 - translating a dividend yield of 0.93%.

    Read More about Dividends

Indices Featuring Lupin Stock

Check stock indices that include Lupin.

Nifty Midcap 50

₹16,410.40

-89.80 (▲0.54%)

Nifty Midcap 100

₹57,100.00

-465.85 (▲0.81%)

Nifty Healthcare

₹15,488.50

-18.65 (▲0.12%)

S&P BSE 250 LargeMidCap

₹10,054.57

-47.33 (▲0.47%)

BSE 100

₹24,217.57

-99.75 (▲0.41%)

Nifty Midcap Sel

₹13,314.55

-53.30 (▲0.40%)

S&P BSE 150 MidCap

₹15,489.06

-102.64 (▲0.66%)

Nifty 500

₹21,702.85

-135.05 (▲0.62%)

BSE 200

₹10,557.57

-48.27 (▲0.46%)

S&P BSE SEN. N50

₹81,000.63

-239.78 (▲0.30%)

Nifty Midcap 150

₹21,040.45

-159.80 (▲0.75%)

S&P BSE Dividend Stability

₹977.93

-6.15 (▲0.62%)

Nifty LargeMidcap 250

₹15,427.65

-99.30 (▲0.64%)

S&P BSE 100 ESG

₹384.62

-1.56 (▲0.40%)

Nifty MidSmallcap 400

₹19,545.90

-159.15 (▲0.81%)

Nifty 200

₹13,026.60

-76.55 (▲0.58%)

S&P BSE Low Volatility

₹1,603.39

-5.87 (▲0.36%)

BSE Healthcare

₹47,387.72

+24.19 (▲0.05%)

NIFTY PHARMA

₹25,551.50

-14.40 (▲0.06%)

BSE 500

₹33,984.43

-169.89 (▲0.50%)

S&P BSE 400 MidSmallCap

₹11,655.19

-80.41 (▲0.69%)

Insights on Lupin Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 21.71% to 22.42% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 5.72K Cr → 8.40K Cr (in ₹), with an average increase of 7.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 40.0% return, outperforming this stock by 38.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Divis Laboratories Ltd has given 162.5% return, outperforming this stock by 94.4%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 16.93% to 14.84% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 6.11% to 6.08% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 1.46K Cr → 1.41K Cr (in ₹), with an average decrease of 3.1% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 46.86% to 46.85% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, LUPIN stock has moved down by -18.4%

Lupin Stock Futures & Options Contracts

View the latest movement in Lupin Futures & Options, including strike prices, expiry dates, and percentage changes.

Lupin Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
LUPIN 27 Oct ₹1940 Call
October 27, 2026
₹1940
₹11.4
-10.75
-48.53%
LUPIN 27 Oct ₹1980 Call
October 27, 2026
₹1980
₹3.9
-3.9
-50%
LUPIN 27 Oct ₹1960 Call
October 27, 2026
₹1960
₹6.65
-7.2
-51.99%
LUPIN 27 Oct ₹1920 Call
October 27, 2026
₹1920
₹20.15
-13.9
-40.82%

Lupin Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
LUPIN 27 Oct Fut
October 27, 2026
-
₹1920
-23.71
-1.22%
LUPIN 23 Nov Fut
November 23, 2026
-
₹1928.5
-24.41
-1.25%
LUPIN 29 Dec Fut
December 29, 2026
-
₹1941.1
-22.98
-1.17%

About Lupin Ltd

Lupin Ltd is a global pharmaceutical company incorporated in 1968 with its headquarters in Mumbai, India. Lupin Ltd operates in several lines of business, including branded and generic formulations, biotechnology, active pharmaceutical ingredients (APIs), and animal health products.

The company's top products include a wide range of prescription and over-the-counter drugs, including antibiotics, cardiovascular medications, antidiabetics, and anti-asthmatics. Lupin Ltd also manufactures and markets a variety of branded products, including Metoject, Lupitac, and Lupizole. In addition, the company produces a number of popular generic drugs, such as Amlodipine, Montelukast, and Cetirizine.

Lupin Ltd is one of the world's leading manufacturers of APIs, with a portfolio that includes more than 200 APIs and intermediates. The company also produces a range of animal health products, such as veterinary vaccines, feed supplements, and pet care products.

Revenue: ₹8,217.23Cr as on June 2026 (Q1 FY27)
Net Profit: ₹1,416.98Cr as on June 2026 (Q1 FY27)
Listing date: 30 Nov, 1994
Chairperson Name: M D Gupta
OrganisationLupin Ltd
IndustryPharmaceuticals
CEOM D Gupta
E-voting on sharesClick here to vote

FAQs

What is Lupin share price today?

Lupin share price today stands at ₹1919.2 as on . Lupin share today touched a day high of ₹1945.7 and a low of ₹1896.1.

What is the 52 week high and 52 week low range for Lupin share?

Lupin touched a 52 week high of ₹2529.5 and a 52 week low of ₹1896.1. Lupin share price today i.e. is trending at ₹1919.2, which is -24.13% down from its 52 week high and 1.22% up from its 52 week low.

What is Lupin's market capitalisation today?

Lupin market capitalisation is ₹89,811.75 Cr as on .

How to buy Lupin shares?

To buy Lupin shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for LUPIN or Lupin Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Lupin shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Lupin trading volume today?

Lupin trading volume is 5.70L as on . This means that 5.70L shares of Lupin were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Lupin shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest in Lupin has decreased while investment activity has increased over the past 30 days, and the average INDmoney investor holds the stock for 31 days. This reflects platform activity only and is not investment advice.